Success rates vary based on multiple factors: Age is the most significant – women under 35 have 60-65% clinical pregnancy rate per cycle, 35-37: 50-55%, 38-40: 40-45%, 41-42: 25-30%, over 42: 10-15% (using own eggs). Other factors: Ovarian reserve (AMH, antral follicle count), sperm quality, uterine receptivity, embryo quality, lifestyle factors (BMI, smoking), and clinic expertise. Cumulative success rates after 3 cycles reach 80-90% for women under 35. Donor egg IVF offers consistent 55-65% success rates regardless of recipient age. Our clinic’s success rates exceed European and Turkish national averages due to advanced technology and personalized protocols.

Most couples (65-70%) achieve pregnancy within 1-2 IVF cycles. Statistics show: First cycle: 50-65% success (under 35), Cumulative after 2 cycles: 75-80%, Cumulative after 3 cycles: 85-90%. The number needed depends on: age, diagnosis, embryo quality, and whether genetic testing (PGT-A) is used. We recommend planning for 2-3 cycles financially and emotionally. Some patients benefit from “back-to-back” cycles (consecutive months), while others need breaks between cycles. After 3 failed cycles with good-quality embryos, we recommend comprehensive evaluation for implantation failure. Many insurance packages offer discounts for multiple cycles purchased together.

IVF is generally safe but has potential risks: Ovarian Hyperstimulation Syndrome (OHSS): 1-5% risk (we use antagonist protocols and trigger modifications to minimize), Multiple pregnancy: 20-30% with double embryo transfer (we strongly recommend single embryo transfer to reduce to 1-2%), Ectopic pregnancy: 2-5% (similar to natural conception), Birth defects: Slightly increased (4-5% vs 3% naturally), Procedure risks: Infection, bleeding at retrieval (less than 1%). Side effects: Medication effects: Bloating, mood swings, injection site reactions, Egg retrieval: Cramping, spotting for 1-2 days, Emotional stress: Common, we provide psychological support. Serious complications are rare (<1%) in experienced centers. We discuss all risks during informed consent and have protocols to minimize them.

Yes, through Preimplantation Genetic Testing (PGT), which can determine chromosomal sex (XX for female, XY for male). However, gender selection for non-medical reasons is strictly regulated in Turkey and many countries. It is permitted only for: 1) Medical reasons: To avoid sex-linked genetic disorders (like hemophilia, Duchenne muscular dystrophy), 2) Family balancing: When a couple has multiple children of one sex and desires a child of the other sex, with specific conditions. Ethical guidelines require counseling about the implications. The process involves: IVF with embryo biopsy, genetic analysis, and transfer of embryo(s) of desired sex. Success rates for gender selection are the same as for PGT cycles (65-75% per euploid embryo transfer). We provide detailed counseling about legal and ethical considerations.

Turkey is a global leader in fertility treatment because: 1) High Success Rates: Often exceeding European averages due to advanced technology and experienced embryologists, 2) Cost-Effectiveness: 60-75% lower costs than Western countries, 3) Advanced Technology: Latest equipment (time-lapse incubators, vitrification systems), 4) Experienced Specialists

High-volume IVF centers with specialists averaging 15+ years experience, 5) Comprehensive Care: All services in one center from diagnosis to delivery, 6) Legal Advantages: More flexible regulations for certain treatments, 7) International Standards: JCI-accredited facilities with English-speaking staff, 8) Tourism Integration: Combine treatment with recovery in beautiful Istanbul. Many couples achieve success in Turkey after failed cycles elsewhere due to personalized protocols and advanced laboratory techniques.